| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jaguar Health, Inc. | Director | Convertible Promissory Note | 9.46K | $473M | $50,000.00 | 24 Jun 2025 | Indirect |
| Jaguar Health, Inc. | Director | Stock option (right to buy) | 26.5K | 08 Oct 2024 | Direct | ||
| Jaguar Health, Inc. | Director | Warrant to Purchase Common Stock | 9K | 24 Jun 2025 | Indirect | ||
| Opy Acquisition Corp. I | Chief Executive Officer, Director | Common Stock | 0 | 26 Oct 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JAGX | Jaguar Health, Inc. | 24 Jun 2025 | 3 | $23.1M | 4 | Director | 26 Jun 2025, 16:42 |
| JAGX | Jaguar Health, Inc. | 31 Mar 2025 | 2 | $450M | 4 | Director | 02 Apr 2025, 20:10 |
| JAGX | Jaguar Health, Inc. | 08 Oct 2024 | 1 | $0 | 4 | Director | 10 Oct 2024, 21:52 |
| JAGX | Jaguar Health, Inc. | 14 Aug 2023 | 1 | $0 | 4 | Director | 14 Aug 2023, 17:53 |
| JAGX | Jaguar Health, Inc. | 17 May 2023 | 2 | $0 | 4 | Director | 19 May 2023, 17:06 |
| JAGX | Jaguar Health, Inc. | 18 May 2022 | 2 | $0 | 4 | Director | 18 May 2022, 16:33 |
| JAGX | Jaguar Health, Inc. | 28 Mar 2022 | 1 | $0 | 4 | Director | 30 Mar 2022, 21:40 |
| OHAA | Opy Acquisition Corp. I | 26 Oct 2021 | 0 | $0 | 3 | Chief Executive Officer, Director | 27 Oct 2021, 14:10 |
| JAGX | Jaguar Health, Inc. | 18 May 2021 | 2 | $0 | 4 | Director | 20 May 2021, 17:08 |